Mehmet Ali Ergün
United States Food and Drug Administration
ORCID: 0000-0002-2480-8077Also affiliated with Center for Drug Evaluation and Research, Food and Drug Administration
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Kathryn P. Lowry, Allison W. Kurian, Jeanne S. Mandelblatt, Mehmet Ali Ergün, Hui Huang +10 more
Papers
Driven by 3 papers — median percentile 0. Top paper: “Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling”.
Kathryn P. Lowry, Allison W. Kurian, Jeanne S. Mandelblatt, Mehmet Ali Ergün, Hui Huang +11 more
Kathryn P. Lowry, Allison W. Kurian, Jeanne S. Mandelblatt, Mehmet Ali Ergün, Hui Huang +10 more
Zhiqun Tang, Adam F Benson, MeLisa R. Creamer, Kathryn C. Edwards, Eva Sharma +15 more